[Clinical trial of a variation of combined radiation therapy of recurrent rectal cancer in women].
The results of clinical testing of the variant of associated radiotherapy for recurrent rectal cancer in 34 female patients are reported. Distant grid gamma therapy in the regime of uneven irradiation was associated with intracavitary irradiation and gammatherapy from open fields. An average focal dose under uneven irradiation was 86 Gy (8600 rad) in intracavitary gammatherapy--30 Gy (3000 rad), in open field irradiation--30 Gy (3000 rad), the radiation stress being 1.5-2 times increased within the limits of normal tisues tolerance compared with routine variants of irradiation. No marked radiation injuries hampering the continuation of the treatment were observed in the period to follow. Among 34 patients in 8 (23.5%) the complete tumor regression was gained.
D000230:Adenocarcinoma / Q000532:radiotherapy; D002288:Adenocarcinoma, Mucinous / Q000532:radiotherapy; D000328:Adult; D000368:Aged; D001918:Brachytherapy / Q000379:methods; D002294:Carcinoma, Squamous Cell / Q000532:radiotherapy; D002986:Clinical Trials as Topic; D005260:Female; D005720:Gamma Rays / Q000627:therapeutic use; D006801:Humans; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000401:mortality / Q000532:radiotherapy*; D011867:Radioisotope Teletherapy / Q000379:methods; D011879:Radiotherapy Dosage; D012004:Rectal Neoplasms / Q000401:mortality / Q000532:radiotherapy*
Klinicheskaia aprobatsiia varianta sochetannoĭ luchevoĭ terapii retsidivnogo raka priamoĭ kishki u zhenshchin.